Answers are grounded in this paper and cite their sources.
Investigations reveal a new synthetic pathway for dialkylated products using dichloro[2.2]paracyclophane.
A transition‐metal‐free alkylation of the dichloro[2.2]paracyclophane scaffold is reported, representing a significant advancement in the reactivity of this unique class of compounds. The pseudo‐ para isomer of dichloro[2.2]paracyclophane was isolated from a commercial mixture via crystallization, and its structure was assessed by detailed 1D and 2D NMR spectroscopy. The reaction of the purified isomer with butyllithium was investigated, and a systematic optimization revealed that reaction rate and selectivity were significantly improved by using a chelating agent and conducting the reaction in refluxing heptane. This refined protocol yielded the desired dialkylated product, establishing a new and more efficient synthetic pathway that opens the door to further exploration of this unprecedented reactivity.
No takes yet. Share an insight, caveat, or question.
Frigatti et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: